168 related articles for article (PubMed ID: 24598448)
21. A Phase II trial of dosage escalation of sorafenib in Asian patients with metastatic renal cell carcinoma.
Wang HK; Zhang HL; Zhu Y; Yao XD; Zhang SL; Dai B; Shen YJ; Zhu YP; Shi GH; Qin XJ; Ma CG; Lin GW; Xiao WJ; Ye DW
Future Oncol; 2014 Oct; 10(12):1941-51. PubMed ID: 25386811
[TBL] [Abstract][Full Text] [Related]
22. A Phase I Trial of Bortezomib and Sorafenib in Advanced Mali
